×
About 778 results

ALLMedicine™ Thermal Burns Center

Research & Reviews  201 results

Fractional Ablative Laser Treatment for Skin Grafts
https://clinicaltrials.gov/ct2/show/NCT04176705

Aug 2nd, 2022 - This pilot study is being conducted to establish safety, however the study team will make multiple measures to measure for efficacy as well. The study team hypothesizes that human split-thickness skin grafts will safely respond similar to the porc...

A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
https://clinicaltrials.gov/ct2/show/NCT02278718

Jul 27th, 2022 - A total of 160 patients will be randomized into NexoBrid and SOC treatment (80 patients per arm). Age distribution will be managed as follows: 45 patients 0-23 months old 45 patients 24 months-3 years old 30 patients 4-11 years old 20 patients 12-...

StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns
https://clinicaltrials.gov/ct2/show/NCT04765202

Jul 26th, 2022 - Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the patient's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns. It works to close the woun...

Use of ovine forestomach matrix in the treatment of facial thermal burns.
https://www.ncbi.nlm.nih.gov/pubmed/35797555
Wounds : a Compendium of Clinical Research and Practice; Al Mousa RH, Bosque BA et. al.

Jul 8th, 2022 - Thermal burn injuries are common, devastating medical emergencies that are challenging to manage. Timely and effective treatment is paramount to both short- and long-term patient outcomes. Currently, medical providers and health care facilities wo...

Platelet distribution width associated with short-term prognosis and cost in paediatric...
https://doi.org/10.1111/iwj.13791
International Wound Journal; Liu H, Li D et. al.

Jun 17th, 2022 - Platelets exert important roles in burn wound healing and involving in inflammatory regulation and tissue repair. Platelet distribution width (PDW) is an indicator representing platelet morphology and activation. In this study, we try to evaluate ...

see more →

Drugs  69 results see all →

Clinicaltrials.gov  24 results

Fractional Ablative Laser Treatment for Skin Grafts
https://clinicaltrials.gov/ct2/show/NCT04176705

Aug 2nd, 2022 - This pilot study is being conducted to establish safety, however the study team will make multiple measures to measure for efficacy as well. The study team hypothesizes that human split-thickness skin grafts will safely respond similar to the porc...

A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
https://clinicaltrials.gov/ct2/show/NCT02278718

Jul 27th, 2022 - A total of 160 patients will be randomized into NexoBrid and SOC treatment (80 patients per arm). Age distribution will be managed as follows: 45 patients 0-23 months old 45 patients 24 months-3 years old 30 patients 4-11 years old 20 patients 12-...

StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns
https://clinicaltrials.gov/ct2/show/NCT04765202

Jul 26th, 2022 - Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the patient's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns. It works to close the woun...

Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
https://clinicaltrials.gov/ct2/show/NCT04684121

Jun 8th, 2022 - Multi-center, prospective, randomized, double-blind, parallel-group, within-subject Vehicle controlled, safety and efficacy trial involving subjects with two comparable (similar body location, similar burn area and burn severity), noncontiguous de...

A Phase 2, Open Label, Randomized, Active-Controlled Pilot Study MW-III vs Silver Sulfadiazine Second Degree Thermal Burns
https://clinicaltrials.gov/ct2/show/NCT01297400

Apr 27th, 2022 - This is an open-label, randomized, active-controlled pilot study to evaluate the efficacy and safety profile of topical MW-III versus an active control (Silvadene® Cream 1% [Silver Sulfadiazine]) in the treatment of second-degree thermal burns in ...

see more →

News  17 results

FDA Approves StrataGraft for Deep Skin Burns
https://www.medscape.com/viewarticle/953353

Jun 18th, 2021 - The US Food and Drug Administration (FDA) has approved a novel regenerative therapy that could be an alternative to autografting for treating adults with severe burns. The new treatment, StrataGraft, is a bilayer tissue engineered to mimic the epi...

Symmetric Drug-Related Intertriginous and Flexural Exanthema
https://www.mdedge.com/dermatology/article/232779/wounds/symmetric-drug-related-intertriginous-and-flexural-exanthema
Dylan Haynes, MD, Zachary Pena, MD et. al.

Dec 3rd, 2020 - To the Editor: Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a curious disorder that has undergone many clinical transformations since first being described by Andersen et al1 in 1984 using the term baboon syndrome. Init.

Clinical Practice Guidelines for the Management of Acute Pain in the Adult Burn Patient (ABA, 2020)
https://reference.medscape.com/viewarticle/938346

Oct 2nd, 2020 - Clinical practice guidelines on the management of acute pain in the adult burn patient were released in September 2020 by the American Burn Association.[1] Elements of the pain assessment are as follows: Perform several times daily. Follow a proto...

BRIEF-Vericel - Submission Of Biologics License Application To FDA For Nexobrid
https://www.reuters.com/article/brief-vericel-submission-of-biologics-li/brief-vericel-submission-of-biologics-license-application-to-fda-for-nexobrid-idUSASA00VD3

Jun 30th, 2020 - June 30 (Reuters) - Vericel Corp: * VERICEL ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO THE FDA FOR NEXOBRID FOR THE TREATMENT OF SEVERE THERMAL BURNS * VERICEL - VERICEL HOLDS AN EXCLUSIVE LICENSE FOR NORTH AMERICAN COMMERCIAL RIGHTS...

BRIEF-Mallinckrodt Completes Rolling Submission Of Biologics License For Stratagraft Regenerative Skin Tissue To FDA
https://www.reuters.com/article/brief-mallinckrodt-completes-rolling-sub/brief-mallinckrodt-completes-rolling-submission-of-biologics-license-for-stratagraft-regenerative-skin-tissue-to-fda-idUSASA00T3E

Jun 9th, 2020 - June 9 (Reuters) - Mallinckrodt Plc: * MALLINCKRODT COMPLETES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR STRATAGRAFT® REGENERATIVE SKIN TISSUE TO U.S. FOOD AND DRUG ADMINISTRATION * MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE IS IN DEV...

see more →